2019 Conference Committee and Sessions

The Pharmabiotics 2019 Scientific Committee (left to right):

  • Bruno Pot, President, Pharmabiotic Research Institute
  • Adrien Nivoliez, CEO, Biose Industrie
  • Magali Cordaillat-Simmons, Scientific & Regulatory Affairs Director, Pharmabiotic Research Institute
  • Marco Pane, R&D Director, Probiotical
  • Travis Whitfill, Chief Scientific Officer, Azitra Inc
  • Ashton Harper, Medical Affairs Director, Protexin
  • Sarah Lebeer, Associate Professor, University of Antwerp
  • Lindsay Hall, Quadrum Institute

With the Committee’s combined and diverse expertise in the science and business of the human microbiome industry, from academic research to regulatory affairs, manufacturing and investing, the conference program will be developed with the aim of bringing our members and community the latest research and innovations throughout the entire development process for microbiotic medicinal products.

Our Call for Abstracts is now open – If you are interested in presenting original research, please apply here.

Topics of Discussion Include:

  • The Microbiome & Cancer: Exploring the Oncobiome
  • Removing Bias in Sampling and Bioinformatics Techniques
  • Navigating Regulatory Pathways for Your Microbiome Products
  • Development Process Technologies: From Bench to Bedside
  • Exploring The Gut-Lung Axis
  • Market Trends and Investment: Beyond the Money
  • Developing Synthetically Engineered Pharmabiotics
  • Discovering the Human Urogenital Microbiome
  • The Latest Innovations from Industry and Academia
  • Advancing Applied Microbiome Research

Leave a Reply

Your email address will not be published. Required fields are marked *